文献速递头颈甲状腺与浅表技术与安全CTUS

CT偶发甲状腺结节随访超声的成本效果分析

Cost-Effectiveness of Follow-Up Ultrasound for Incidental Thyroid Nodules on CT.
PubMed 文献 · AJR Am J Roentgenol · 2021-10-20

该模拟模型纳入1,000,000名成人,甲状腺结节≤40 mm且无可疑特征,评估基于年龄和大小 cutoff 的随访策略。所有成本效果策略均建议年龄超过 cutoff(25-65岁)者不随访;最佳策略为<60岁且结节≥10 mm随访、≥60岁不随访,增量成本效果比为$50,196/QALY(95% CI, $39,233-67,479)。若未治疗癌症10年疾病特异性生存超过治疗者的94%,则任何结节均不随访为最优。

要点

  • CT偶发甲状腺结节≤40 mm且无可疑特征时,所有成本效果策略均建议年龄超过25-65岁 cutoff 者不随访。
  • 最佳策略为<60岁且结节≥10 mm随访、≥60岁不随访,增量成本效果比$50,196/QALY(95% CI, $39,233-67,479)。
  • 若未治疗癌症10年疾病特异性生存超过治疗者的94%,则任何结节均不随访为最优。

核心结论

  • CT偶发甲状腺结节随访超声在老年患者中可能不具有成本效果;年轻患者中大多数结节的随访可能具有成本效果。

研究设计与样本

  • 模拟模型研究,纳入1,000,000名成人,甲状腺结节≤40 mm且无可疑特征;评估结节大小 cutoff 5-25 mm、年龄上限25-65岁,以及年龄超过上限者随访与不随访策略;以疾病特异性死亡率、基线死亡率和手术死亡率确定生存,计算成本和QALYs,并进行概率敏感性分析。

诊断标准与关键数值

  • 在支付意愿阈值$100,000/QALY下,10种策略具有成本效果;最佳策略为<60岁且结节≥10 mm随访、≥60岁不随访,增量成本效果比$50,196/QALY(95% CI, $39,233-67,479)。

临床应用与阅片要点

  • 作者指出,未来学会推荐可能考虑老年患者CT偶发甲状腺结节随访获益有限。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Thyroid nodules are common incidental findings on CT. Existing professional society recommendations, based primarily on expert opinion, advise follow-up ultrasound for nodules above size cutoffs in patients of all ages. OBJECTIVE. The purpose of this study was to use a simulation model to evaluate the cost-effectiveness of current recommendations and of other age- and size-based follow-up strategies for thyroid nodules incidentally detected on CT. METHODS. By using a simulation model with 1,000,000 adults with nodules measuring 40 mm or less that have no suspicious features, we evaluated size cutoffs from 5 to 25 mm in patients younger than an age maximum from 25 to 65 years, as well as follow-up versus no follow-up for patients above the age maximum. For each strategy, patient survival was determined by disease-specific and baseline mortality rates and surgical mortality. Costs and quality-adjusted life years (QALYs) were tabulated. A probabilistic sensitivity analysis was performed with varying model parameters. RESULTS. All cost-effective strategies recommended no follow-up for patients above the age cutoffs (which varied from 25 to 65 years). In the base-case simulation, 10 strategies were cost-effective at a willingness-to-pay threshold of $100,000/QALY. Of these, the strategy yielding the highest QALYs was follow-up for patients under 60 years old with nodules 10 mm or larger and no follow-up for patients 60 years old or older, with an incremental cost-effectiveness ratio of $50,196/QALY (95% CI, $39,233-67,479). In the probabilistic sensitivity analysis, if the 10-year disease-specific survival of patients with untreated cancer was more than 94% of patients with treated cancer, then no follow-up for any nodules was optimal. CONCLUSION. Follow-up ultrasound for thyroid nodules incidentally detected on CT is likely not cost-effective in older patients. Follow-up for most thyroid nodules in younger patients may be cost-effective. CLINICAL IMPACT. Future societal recommendations may account for the limited benefit of obtaining follow-up for incidental thyroid nodules on CT in older patients.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Hammer MM, Kong CY. Cost-Effectiveness of Follow-Up Ultrasound for Incidental Thyroid Nodules on CT. AJR Am J Roentgenol. 2021. PMID: 34668384. doi:10.2214/AJR.21.26786

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。